Sodium Deficiency in the Body – Causes, Symptoms, and Treatment

Hyponatremia represents one of the most frequently encountered disturbances in water-electrolyte balance within clinical settings, as evidenced by comprehensive data compiled by the Department of Nephrology, Hypertension, and Kidney Transplantation in Łódź. Statistical analyses indicate that this condition affects approximately 15–20% of all hospitalized patients, with prevalence rates climbing to 20% among those in critical care units. The reduction of serum sodium concentrations below the 135 mmol/l threshold not only correlates with prolonged hospital stays but also predisposes individuals to a broad spectrum of clinical manifestations—ranging from mild symptomatology to acute, life-endangering complications. Serum sodium concentration, or natremia, remains a cornerstone of routine laboratory assessment, given that its reference interval spans 135–145 mmol/l. From a pathophysiological perspective, this electrolyte imbalance may coexist with three distinct volume states: hypovolemia (diminished circulating blood volume), normovolemia (absence of edema), or hypervolemia (expanded intravascular fluid compartment).

Reduced serum sodium ion concentration may arise from multifactorial disruptions in electrolyte homeostasis, encompassing both exogenous and endogenous contributors. The most significant etiologies include: **prolonged adherence to severely sodium-restricted diets** (though isolated instances of this nature remain comparatively uncommon in clinical settings); **hypotonic hyperhydration** induced by **excessive fluid intake during extreme physical exertion**, commonly referred to as **water intoxication**; **improper or uncontrolled use of diuretic agents**—including both thiazide and loop diuretics; **thyroid gland dysfunction**, particularly **hypothyroidism**; **hormonal dysregulation** associated with **inappropriate vasopressin secretion** (SIADH—*Syndrome of Inappropriate Antidiuretic Hormone Secretion*); **electrolyte depletion via excessive sweating** during **sustained physical activity under high-temperature conditions**; **renal pathologies**, primarily **chronic kidney failure**; and **substantial losses of sodium and water through the gastrointestinal tract** due to **chronic diarrhea**, **persistent vomiting**, or **intestinal obstruction**

The clinical presentation of hyponatremia is primarily contingent upon the rate at which the electrolyte imbalance develops and its overall severity. When sodium depletion is identified within the initial 48-hour window following onset, it is categorized as the acute form of the condition. Conversely, if the deficiency persists beyond 48 hours, it is classified as chronic hyponatremia. Available epidemiological evidence indicates that the most frequently reported patient complaints include: generalized physical debility (observed in 49% of cases), recurrent episodes of vertigo (47% of presentations), vomiting (35% of affected individuals), psychomotor confusion (17% of incidents), syncopal or presyncopal events (17% of cases), persistent headaches of varying severity (6% of diagnoses), and infrequent but potentially serious convulsive episodes (0.9% of presentations).

The therapeutic management of hyponatremia necessitates a tailored approach that accounts for the specific subtype of the disorder and the patient’s clinical presentation. In hypovolemic cases, the cornerstone of intervention involves the administration of isotonic (0.9%) sodium chloride solution to restore intravascular volume. Normovolemic hyponatremia, which typically follows a milder course, is managed based on the severity of clinical manifestations, with treatment decisions guided by symptomatic assessment. Conversely, the hypervolemic variant mandates fluid restriction, the use of hypertonic (3%) NaCl solutions, and—where clinically indicated—the introduction of vaptans, a class of vasopressin receptor antagonists. In refractory or severe cases, renal replacement therapy may be considered as a last-resort measure.